Neutropenia Febrile clinical trials

Explore recruiting neutropenia febrile clinical trials.

Recruiting neutropenia febrile studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Neutropenia Febrile trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

FUDOSE: Dihydropyrimidine dehydrogenase (DPD) phenotype-guided dose individualization of fluoropyrimidinebased chemotherapy in DPD deficient patients with gastrointestinal cancers.

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Neutropenia Febrile trials by city

Neutropenia Febrile clinical trials

Recruiting neutropenia febrile studies right now

Short Antibiotic Treatment in High Risk Febrile Neutropenia

Ciprofloxacin vs Ceftazidime for Empirical Treatment of High-Risk Neutropenic Fever in Children With Hematologic Malignancies

Ceftolozane/Tazobactam Versus Meropenem for Febrile Neutropenia on Patients Colonized With or at Risk for Infection With Extended Spectrum Beta Lactamase - Producing Pathogens

Early Versus Late Stopping of Antibiotics in Adults With High-risk Hematological Malignancies/Receiving Cellular Therapies and Fever

Antibiotic Duration and Outcomes in High-Risk Febrile Neutropenia Patients

The Ambient Light Multiple Myeloma Study

Clinical Study of Thiopegfilgrastim for Preventing Bone Marrow Suppression in Thoracic Tumor Chemoradiotherapy

Efbemalenograstim Alfa for Primary/Secondary Prevention in Patients With Solid Tumors at High Risk for Febrile Neutropenia (FN) or Intermediate Risk of Chemotherapy Regimens Associated With Other Risk Factors in FN

Early De-escalation of Empirical Antibiotics Treatment for Neutropenic Fever

Stopping Antibiotics After 3 Days for the Treatment of High-risk FEbrile Neutropenia

Adjustment of Antibiotic Dosage in Pediatric Oncology Patients With Febrile Neutropenia and Augmented Renal Clearance

ECM and Monitoring w/ Alio Smart Patch in Cancer Pts Receiving Chemotherapy

Also recruiting in Europe

FUDOSE: Dihydropyrimidine dehydrogenase (DPD) phenotype-guided dose individualization of fluoropyrimidinebased chemotherapy in DPD deficient patients with gastrointestinal cancers.

Neutropenia Febrile trials by city

Other conditions